Lung Cancer Surgery Market Trend | Industry Analysis Report, 2025
Around 87% of lung cancers occur due to tobacco, smoking, passive smoking, and inhalation of any carcinogenic substance. On the other hand, genetic predisposition either directly causes cancer or increases the chances of developing lung cancer due to exposure to certain environmental factors. Lung cancer can be diagnosed through biopsy which is carried out using bronchoscopy or CT-guidance. A combination of surgery, chemotherapy, targeted therapy, immunotherapy, and radiation therapy are involved in the treatment of lung cancer. Lung cancer surgery is the surgical ablation of cancer tissue from the lung. The type of surgery depends upon the size of the tumor and its position within the lung. This treatment option is majorly used to treat non-small cell lung cancer. The Lung Cancer Surgery Market is likely to grow due to high success rates as compared to other therapies available.
Request to View Brochure of Report -
The lung cancer surgery market can be divided into two segments -based on types of surgery available and products used (surgical & monitoring devices). Four types of surgery can be performed to treat lung cancer. These are pneumonectomy, lobectomy, segmentectomy or wedge resection, and sleeve resection. Pneumonectomy is removal of the entire lung through surgery and lobectomy is the removal of the entire cancer affected lobe of the lung. In segmentectomy, a small wedge shaped piece of lung is excised. In sleeve resection, healthy parts are reconnected after the removal of the cancerous part of the bronchus. On the basis of products used, lung cancer surgery can be classified into minimally invasive surgical procedures (such as video-assisted thoracoscopic surgery), robot assisted surgery, and percutaneous transcatheter surgery (radiofrequency ablation, cryoablation).
Rising occurrence of lung cancer due to change in lifestyle, increase in the number of smokers, and rise in the level of air pollution, and technological advancements in the field of minimally invasive surgeries are some of the reasons enhancing the growth of the market. According to National Cancer Institute, the number of deaths due to lung cancer accounted for around 160,340 in 2012 and there were around 220,160 new lung cancer diagnosis cases in the same year. World Health Organization (WHO) claims around 1,824,701 deaths annually due to lung cancer and that accounts for 13% of total lung cancer cases diagnosed in adults in 2012. Novel surgical approaches like robotic surgery and other technological advancements further boosts the growth of the market. On the other hand, lack of surgical expertise, effective alternative treatments, limited accessibility to novel approaches, abrupt location & large size of the tumor, post-surgery pain, and high cost are some of the restraints faced by the market. High growth potential in the Asian region provides opportunities for players in the lung cancer surgery market.
Request to View ToC of Report -
Geographically, the market for lung cancer surgery can be distributed into five regions i.e. North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global lung cancer surgery market. According to World Cancer Research Fund International, the highest incidence of lung cancer was observed in Northern America followed by the Asia Pacific region. Rise in the aging population, increasing incidence of lung cancer, and reimbursement available for lung cancer surgery are some factors that drives the growth in the North American market. However, Asia is expected to expand at the highest growth rate rapidly as expensive robotic surgeries are being carried out for treatment, which is anticipated to contribute to the growth of the global lung cancer surgery market. Factor such as growing population, increase in the number of newly diagnosed patients, government initiatives for improvement of healthcare infrastructure, and increasing healthcare expenditure in Asian countries are driving the market. In Europe, Hungary had the highest rate of lung cancer, followed by Serbia. In Latin America and the Middle East & Africa, the incidence of lung cancer is comparatively lower than most developed countries.
Covidien PLC, Ethicon US LLC, AngioDynamics Inc., Intuitive Surgical Inc., Accuray Inc., Teleflex Inc., Scanlan International Inc., Olympus Corporation, KARL STORZ GmbH, Ackermann Instrumente GmbH, and Trokamed GmbH are some of the key players of the lung cancer surgery market.
View Report -
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lung Cancer Surgery Market Trend | Industry Analysis Report, 2025 here
News-ID: 962471 • Views: 109
More Releases from Transparency Market Research
Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the
More Releases for Lung
Interstitial Lung Disease Therapeutics - Pipeline Analysis 2018
Interstitial lung disease is a type of inflammatory disease that affects and thickens the interstitium of the lungs. Download the sample report @ https://www.pharmaproff.com/request-sample/1126 The interstitium is a lace like network of the tissue that provide support to the air sacs and the capillaries in the interstitium which allows the gas exchange between the blood and alveolar tissues. Get the detailed analysis @ https://www.pharmaproff.com/report/interstitial-lung-disease-therapeutics-pipeline-analysis Some of the types of the condition include
Lung Cancer and Therapies Meet 2019
Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products. It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques to treat Lung Cancer with different approach. This meet enlightens
Lung Cancer Surgery Market Forecasts (2016-2021)
Lung Cancer Surgery Market was worth USD 21.58 billion in 2016 and is expected to reach USD 30.32 billion by 2021 with a CAGR of 6.92 %. Lung Cancer is a type of Cancer that starts in Trachea, Bronchus or lung Tissue. They are many ways to treat Lung Cancer. Some of them are Chemotherapy, Radiotherapy, Laser therapy, and Surgery. Surgery involves removal of infected section from lungs. There are many
Acute Lung Injury Market Technological breakthroughs 2025
Acute lung injury (ALI) is commonly characterized by hypoxia, lung complication and pulmonary edema. This condition causes inflammation or direct injury to the lungs. Generally, the symptoms of this disease are divided into two forms namely, primary ALI and secondary ALI. Primary ALI is caused by the conditions like pneumonia. While, secondary ALI is mainly caused by indirect injury to the lungs. Inhalation injury, pulmonary contusions, sever trauma, shock are
Lung Cancer Treatment Market Outlook to 2022
Market Overview, Key in-line Products, Market Share Distribution, Competitive Dynamics, Regulatory Outlook, Pipeline Development, Growth Catalysts & Challenges, Leading Market & R&D Trends, Partnership & Deals Analyses, Global Sales forecast of in-line and pipeline products, Fast Growing Private Companies, Management Perspectives, Commentaries, Market Outlook & Summary Conclusions The global lung cancer drugs market was valued at $3.1bn in 2016 and is forecast to grow at a healthy 31.1% CAGR between 2016
Europe Lung Cancer Drug Pipeline Analysis
The most common type of cancer in terms of incidence and mortality rate is Lung cancer. Lung cancer is a disease in which the lining of the cell of the lung tissue has an uncontrollable growth which in turn leads to the formation of tumor. There are two main types of lung cancer; small cell lung cancer which accounts for about 20% and non-small cell lung cancer (NSCLC) that accounts